RecruitingNot ApplicableNCT07567027

Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)

Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR) Trial

Sponsor

NYU Langone Health

Enrollment

20 participants

Start Date

Jun 17, 2026

Study Type

INTERVENTIONAL

Conditions

Prostate Cancer (Diagnosis)Transperineal Cryoablation

Summary

The purpose of this study is to evaluate the feasibility, safety, and potential protective benefit of Barrigel, a hyaluronic acid-based rectal spacer, in patients undergoing prostate cryoablation for localized or recurrent prostate cancer. The primary aim is to assess Barrigel thermal stability during cryoablation.

Eligibility

Sex: MALEMin Age: 40 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Barrigel Injectable Gel and a procedure called Cryoablation for people with prostate cancer (diagnosis) and transperineal cryoablation. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 40 Years to 95 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBarrigel Injectable Gel

Barrigel is a hyaluronic acid-based absorbable perirectal spacer.

PROCEDURECryoablation

Minimally invasive treatment for both localized and recurrent prostate cancer.

Locations(1)

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07567027

Related Trials

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

NCT072233851 location

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

NCT065590595 locations